Clinical studies recruiting near Wynnewood

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Lankenau Medical Center · NRG Oncology · NCT05624996 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Alliance Cancer Specialists, PC · Pfizer · NCT07144280 Trisol System EFS Study
NA · Main Line Health / Lankenau Institute for Medical Research · Trisol Medical · NCT04905017 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified C
NA · Main Line Health · Shockwave Medical, Inc. · NCT07062471 The THOR IDE Study
NA · Lankenau Institute for Medical Research · Philips Clinical & Medical Affairs Global · NCT05916950 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Lankenau Medical Center · NRG Oncology · NCT03180268 Medtronic Terminate AF Study
NA · Lankenau Medical Center · Medtronic Cardiac Surgery · NCT03546374 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · Lankenau Medical Center · Canadian Cancer Trials Group · NCT05640999 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Lankenau Medical Center · National Cancer Institute (NCI) · NCT05256225 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Lankenau Medical Center · National Cancer Institute (NCI) · NCT06498635 Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Phase 3 · Lankenau Medical Center · NRG Oncology · NCT05646316 PARTNER 3 Trial - Aortic Valve-in-Valve
NA · Lankenau Medical Center · Edwards Lifesciences · NCT03003299 DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Phase 2 · Lankenau Medical Center · QuantumLeap Healthcare Collaborative · NCT06075953 A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary
Phase 2 · Site 0277 - Alliance Cancer Specialist, PC · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis P · NCT05128825 The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
Phase 3 · Main Line Health · Main Line Health · NCT06439524 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Lankenau Medical Center · National Cancer Institute (NCI) · NCT06058377 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Lankenau Medical Center · ECOG-ACRIN Cancer Research Group · NCT04239573 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Lankenau Medical Center · National Cancer Institute (NCI) · NCT05564377 Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Phase 3 · Lankenau Medical Center/Mainline Medical Center · GOG Foundation · NCT05659381 The CONFORM Pivotal Trial
NA · Lankenau Heart Institute · Conformal Medical, Inc · NCT05147792 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Lankenau Medical Center · SWOG Cancer Research Network · NCT03418961 ELEVATE-HFpEF Clinical Study
NA · Lankenau Institute for Medical Research · Medtronic Cardiac Rhythm and Heart Failure · NCT06678841 REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Phase N/A · Lankenau Medical Center · Medtronic Cardiovascular · NCT06777368 Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Phase 2 · Alliance Cancer Specialists, PC, Wynnewood · Boehringer Ingelheim · NCT06581432 Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NA · Lankenau Heart Institute · Edwards Lifesciences · NCT04097145 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Lankenau Medical Center · National Cancer Institute (NCI) · NCT04267848 An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Pat
Phase 4 · Research Site · AstraZeneca · NCT07357597 Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
Phase N/A · Lankenau Institute for Medical Research (LIMR) · Galvanize Therapeutics, Inc. · NCT05851430 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Lankenau Medical Center · SWOG Cancer Research Network · NCT03851445

Look up another city

Look up another condition